Identification of group B streptococcus in thirty minutes, and use of FC-fragment to eliminate interference caused by staphylococcus Jonathan Faro, Gerald.

Slides:



Advertisements
Similar presentations
Supplementary Figure 3 A
Advertisements

Enzyme Linked Immunosorbent Assay
By Gracie Canales August 10, 2010
Capability of Immobilisation techniques and detection of Ab-Ag interactions by Eyad Hamad November 2010.
Experiment five Isolation and Identification of influenza virus.
Recombinant Expression of PDI in E. coli
Western Analysis Laboratory procedure that allows you to:
ELISA Enzyme Linked Immunosorbent Assay. Definitions  Antibodies (also known as immunoglobulins abbreviated Ig) are gamma globulin proteins that are.
Clinical Microbiology and Immunology 1 36 Copyright © McGraw-Hill Global Education Holdings, LLC. Permission required for reproduction or display.
QUICKVUE FLEX STREP A TEST. INTENDED USE The QuickVue Flex Strep A Test allows for the rapid detection of group A streptococcal antigen directly from.
EURO-DIAGNOSTICA B.V. The Netherlands For all information, please contact authorized European representative and distributor: Diagnostics Center “EUROTEST”
Enzyme Linked Immunosorbent Assay ELISA Detection of Anti-HIV (This outline summarizes key points of ELISA protocol as outlined in the handout.)
Diagnostic Microbiology and Immunology
Measurement in Science Bioassays and Immunoassays Karim Meeran 23 October 2009.
Introduction to Immunoassays
Enzyme-linked Immunosorbent Assay
ELISA to Measure Cytochrome P450 Protein Concentration by: William Collins.
One of the most useful ways to test a humoral (antibody) response is to inoculate (immunize) an animal with an antigen (foreign substance) and then measure.
Which plant is transgenic? Determination using an enzyme-linked immunosorbent assay.
Altogen Labs, 4020 S Industrial Dr, Suite 130, Austin TX 78744, USA  ELIS A Enzyme-Linked Immunosorbent Assay ELISA.
Enzyme-Linked Immunosorbent Assay ELISA 1Dr. Nikhat Siddiq.
(Enzyme Linked Immunosorbent Assay)
Microbiological Considerations in Diagnosing S. aureus Bacteremia Patrick R. Murray, Ph.D. NIH Clinical Center Chief, Microbiology Laboratories.
Lab 24 Goals and Objectives: EDVOKIT#271: Simulation of HIV-1 Detection: ELISA Work in pairs: ten groups possible Perform as indicated (supplemental packet.
Agglutination tests HA & HI.
Enzyme-Linked Immunosorbent Assay
Serum dilution OD 405 nm PNAG CP5 CP8 AB C Supplemental Figure 1: ELISA analysis of IgG antibody binding in the pre-immune sera of the 9 groups of mice.
Immunology ANTIBODIES we have ~10 12 antibodies made against foreign viruses, bacteria, parasites (vaccines) antibodies combine with foreign antigens to.
WHAT IS A WESTERN BLOT?.
Laboratory diagnosis of infectious and non infectious diseases The methods employed in the laboratory for diagnosing infectious (bacterial, viral, fungal,
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
Enzyme Linked Immunosorbent Assay (ELISA). ELISA Enzyme Linked Immunosorbent Assay (ELISA) Term Was Coined By Engvall and Pearlmann in 1971 Different.
Enzyme-Linked Immunosorbent Assay [ELISA] BCH 462[practical] Lab#5.
Antibody Detection. Part II Detection of Antigens Western Blotting “Dot-Blot Assay” Positive Control Primary antibody (IgY) Lysed E. Coli Cells Lysed.
2. Basic Immunologic Procedures Part 5 Agglutination
Ex. 27: HIV ELISA, AIDS Diagnostic Tool. Human Immuno- deficiency Virus (HIV) First diagnosed in 1981 Over 20 million deaths worldwide, over a half million.
The Enzyme Linked Immunosorbent Assay (ELISA).. Capture ELISAs Antigen Capture: In this, more specific approach, a capturing Ab is adsorbed onto the solid.
ELISA Nada Mohamed Ahmed , MD, MT (ASCP)i.
Human Immunodeficiency Virus (HIV) First diagnosed in 1981 Over 20 million deaths worldwide, over a half million in the United States Over 40 million currently.
Enzyme linked immunosorbent assay
Western Blotting. Introduction … Western blotting, also known as immunoblotting or protein blotting, is a technique used to detect the presence of a specific.
IMMUNOLOGY.
Biochemical instrumental analysis - 12 Dr. Maha Al-Sedik 2015 CLS 332.
Lab 24 Goals and Objectives: EDVOKIT#271: Simulation of HIV-1 Detection: ELISA Work in pairs: ten groups possible Perform as indicated (supplemental packet.
Laboratory #2: ELISA Immuno Explorer
Biomedical Science Activity ELISA
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
Copyright © 2015 Beck, Eric T. Eric T. Beck 1, Garrett C. Reymann 1, Blake W. Buchan 1,2, and Nathan A. Ledeboer 1,2 1 Department.
CONCLUSIONS Amended Abstract Detection of GBS Directly from ESwab Collected Samples Using the BD MAX™ GBS Assay Suzane Silbert, Talita T. Rocchetti, Alicia.
Stool Culture, E. coli O157:H7
Jeanine Spielberger MD 9/23/2013 INTRAPARTUM ANTIBIOTIC PROPHYLAXIS FOR GROUP B STREPTOCOCCAL INFECTION.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
ELISA BASICS.
OBJECTIVE CONCLUSIONS ABSTRACT Establishment of ELISA for AgI/II protein detection using monoclonal anti-AgI/II antibody Jae-Gon Kim, jeong-Yeol Park,
Figure e-1 A. Detection of anti-TIF1-γ antibody.
Development of a Novel Antibody-Based Assay for Simultaneous Identification of a Pathogen and Determination of its Antimicrobial Susceptibility Jonathan.
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Enzyme Linked Immunosorbent Assay
ELISA for mAb detection and Quantification
Haemagglutination assay
Enzyme-Linked Immunosorbent Assay ELISA
Antibody-Antigen Reactions
Enzyme-Linked Immunosorbent Assay [ELISA]
ELISA Immuno ExlorerTM HIV/AIDS Diagnostic Tool
ELISA Immuno ExlorerTM HIV/AIDS Diagnostic Tool
Development of an IL-6 Assay on MagPlex®-Avidin Microspheres using Rapid IgG Biotinylation and RPE-IgG labeling kits Jim Lazar and Alvydas Ozinskas, Moss,
Ebola Virus, Neutrophils, and Antibody Specificity
N-Assay Overview and Potential
N-Assay Overview and Potential
Histone H4 Is a Major Component of the Antimicrobial Action of Human Sebocytes  Dong-Youn Lee, Chun-Ming Huang, Teruaki Nakatsuji, Diane Thiboutot, Sun-Ah.
Presentation transcript:

Identification of group B streptococcus in thirty minutes, and use of FC-fragment to eliminate interference caused by staphylococcus Jonathan Faro, Gerald Riddle, Karen Bishop, Allan Katz, Sebastian Faro UT Health Science Center at Houston, Obstetrics, Gynecology and Reproductive Sciences, Houston, TX ABSTRACTMETHODSRESULTS CONCLUSIONS ACKNOWLEDGEMENTS REFERENCES Objectives: A 6.5-hour diagnostic test for detection of group B streptococcus has recently been described: Through conversion of this test to an ELISA format, we show that purified GBS may be reliably identified in 30 minutes. Methods: Microtiter wells were coated with polyclonal rabbit antibody against GBS (Virostat 1521) at a 1:100 dilution, 100 microliters/well. After incubating overnight at 4 o C and then washing, wells were washed with phosphate buffered saline (PBS). Wells were then blocked with either 5% milk or StartingBlock (Pierce) for 1 hour at room temperature, and then washed with PBS. GBS (10 7 bacteria/well) was added with one of the following commonly isolated co- colonizers: Staphylococcus aureus, Enterococcus faecalis, E. coli, Neisseria gonorrhea, Candida albicans, or Groups A, C, F, or G streptococcus. GBS was diluted serially as the additional co- colonizer was held constant at 10 7 bacteria/well. After incubating for 20 minutes at 37 o C, wells were washed and then HRP-conjugated anti-GBS polyclonal antibody was added, and bound GBS was detected after adding tetramethylene blue (TMB) solution. In order to decrease interference due to S. aureus, Triclosan, Protein A and Fc antibody fragment were used to coat separate wells prior to incubating the bacterial supernatants. The bacterial suspensions were then allowed to stand in these coated wells at room temperature for 30 minutes prior to being placed in the antibody-coated wells. The remainder of assay proceeded as described above. Results: GBS was reliably detected in under thirty minutes, with significant interference due to staphylococcus aureus noted. This interference was completely abrogated by placing the suspensions in Fc-coated wells prior to incubating in antibody-coated wells. The use of Protein A or Triclosan did not show any benefit. Conclusions: GBS may be detected in 30 minutes, after allowing the bacteria to stand in Fc- coated wells to remove interference by S. aureus. No interference was observed when other commonly isolated co-colonizers were examined. Learning Objective: Learners will be able to review CDC screening guidelines for prevention of GBS, and to demonstrate methods for reduction of interference in an immunoassay. INTRODUCTION Screening for GBS is recommended between weeks gestation 1 Routine culture requires hours, with determination of antimicrobial susceptibility requiring an additional hours 2 Per 2010 CDC Guidelines, Identification of GBS by polymerase chain reaction (PCR) may be done after an enrichment step, allowing for a more rapid identification of GBS 3 In order for a test to be utilized in intrapartum patients on the labor and delivery unit, an accurate result must be able to be obtained in under 30 minutes 3  Partial funding for this research was provided by Nanologix, Inc. 1.CDC. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR 2002;51(No. RR-11) 2.Montague NS, Cleary TJ, Martinez OV, Procop GW. Detection of group B streptococci in Lim broth by use of group B Streptococcus peptide nucleic acid fluorescent in situ hybridization and selective and nonselective agars. J Clin Microbiol : CDC. Prevention of perinatal group B streptococcal disease revised guidelines from CDC, MMWR 2010;59(No. RR-10) 4.Faro J, Bishop K, Riddle G, Ramirez M, Katz A, Turrentine M, Faro S. Accuracy of an accelerated, culture-based assay for detection of group B streptococcus. Infect Dis Obstet Gynecol 2013: Microtiter wells were prepared based on the method previously described in which antibody-coated nitrocellulose membranes served as the binding substrate. 4 Wells were coated with either antibody specific to GBS, or to other bacteria/fungi, and included antibody to Enterococcus, Candida albicans, and E. coli as negative controls (not shown). After wells were coated and washed with PBS, bacterial suspensions were added in serial dilutions, starting at 10 7 bacteria/well, and diluting out to 10 1 bacteria per well. The optical density was read at 450 nm. In order to determine specificity, GBS in increasing degrees of dilution was added in the presence of either Staphylococcus aureus, Enterococcus faecalis, E. coli, Neisseria gonorrhea, Candida albicans, or Groups A, C, F, or G streptococcus, each held steady at 10 7 bacteria per well. After incubating at 37 o C for 20 minutes, bound antibody was detected by the addition of HRP-conjugated anti-GBS antibody, and results were obtained once TMB was added and allowed to react with HRP-conjugated antibody. In order to eliminate the high level of interference observed when S. aureus was added, bacterial suspensions were first allowed to stand in tubes coated with varying concentrations of either Protein A, Triclosan, or Fc- Fragment. Aliquots were then removed from these tubes and added to the antibody-coated wells, and the assay proceeded as described above. Purified GBS may be identified in 30 minutes by this ELISA-based assay Of the commonly isolated co-colonizers tested, S. aureus binds to anti-GBS antibody coated wells presumably by binding to the non-antigen binding site Interference due to S. aureus may be completely eliminated by allowing the bacterial suspension to first stand in tubes coated with purified Fc-fragment Figures 1-4: Interference caused by binding to S. aureus is completely abrogated by first incubating the bacterial mixture in the presence of Fc-Fragment. Fig 1 shows two unique GBS isolates identified by ELISA. Fig 2 shows that S. aureus displays a high degree of interference when not incubated first in Fc-Fragment. Fig 3 illustrates that Fc-Fragment does not interfere with GBS binding. Fig 4 demonstrates that interference caused by S. aureus is completely abrogated when a mixture of GBS and S. aureus is first incubated in the presence of Fc-Fragment